Search Results

There are 17621 results for: content related to: Levodopa-dyskinesia incidence by age of Parkinson's disease onset

  1. You have free access to this content
    Abstracts

    Movement Disorders

    Volume 32, Issue S2, June 2017, Pages: S1–S627,

    Version of Record online : 2 JUN 2017, DOI: 10.1002/mds.27087

  2. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 27, Issue S1, June 2012, Pages: S1–S523,

    Version of Record online : 19 JUN 2012, DOI: 10.1002/mds.25051

  3. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 29, Issue S1, May 2014, Pages: S1–S571,

    Version of Record online : 6 JUN 2014, DOI: 10.1002/mds.25914

  4. You have free access to this content
    Poster Session

    Movement Disorders

    Volume 31, Issue S2, June 2016, Pages: S1–S697,

    Version of Record online : 19 JUN 2016, DOI: 10.1002/mds.26688

  5. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 30, Issue S1, June 2015, Pages: S1–S567,

    Version of Record online : 12 JUN 2015, DOI: 10.1002/mds.26295

  6. Clinical pattern and risk factors for dyskinesias following fetal nigral transplantation in Parkinson's disease: A double blind video-based analysis

    Movement Disorders

    Volume 24, Issue 3, 15 February 2009, Pages: 336–343, C. Warren Olanow, Jean-Michel Gracies, Christopher G. Goetz, A. Jon Stoessl, Thomas Freeman, Jeffrey H. Kordower, James Godbold and Jose A. Obeso

    Version of Record online : 12 NOV 2008, DOI: 10.1002/mds.22208

  7. Miscellaneous treatments for neuroleptic-induced tardive dyskinesia

    Intervention Review

    The Cochrane Library

    Karla Soares-Weiser, Claire B Irving and John Rathbone

    Published Online : 22 APR 2003, DOI: 10.1002/14651858.CD000208

  8. The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease

    Movement Disorders

    Volume 26, Issue S3, October 2011, Pages: S2–S41, Susan H. Fox, Regina Katzenschlager, Shen-Yang Lim, Bernard Ravina, Klaus Seppi, Miguel Coelho, Werner Poewe, Olivier Rascol, Christopher G. Goetz and Cristina Sampaio

    Version of Record online : 21 OCT 2011, DOI: 10.1002/mds.23829

  9. Task force report on scales to assess dyskinesia in Parkinson's disease: Critique and recommendations

    Movement Disorders

    Volume 25, Issue 9, 15 July 2010, Pages: 1131–1142, Carlo Colosimo, Pablo Martínez-Martín, Giovanni Fabbrini, Robert A. Hauser, Marcelo Merello, Janis Miyasaki, Werner Poewe, Cristina Sampaio, Olivier Rascol, Glenn T. Stebbins, Anette Schrag and Christopher G. Goetz

    Version of Record online : 22 MAR 2010, DOI: 10.1002/mds.23072

  10. Cholinergic medication for neuroleptic-induced tardive dyskinesia

    Intervention Review

    The Cochrane Library

    Irina Tammenmaa, John McGrath, Eila ES Sailas and Karla Soares-Weiser

    Published Online : 22 JUL 2002, DOI: 10.1002/14651858.CD000207

  11. Preventing and controlling dyskinesia in Parkinson's disease—A view of current knowledge and future opportunities

    Movement Disorders

    Volume 23, Issue S3, 2008, Pages: S585–S598, Peter Jenner

    Version of Record online : 9 SEP 2008, DOI: 10.1002/mds.22022

  12. Translation of nondopaminergic treatments for levodopa-induced dyskinesia from MPTP-lesioned nonhuman primates to phase IIa clinical studies: Keys to success and roads to failure

    Movement Disorders

    Volume 21, Issue 10, October 2006, Pages: 1578–1594, Susan H. Fox, Anthony E. Lang and Jonathan M. Brotchie

    Version of Record online : 27 JUL 2006, DOI: 10.1002/mds.20936

  13. Calcium channel blockers for neuroleptic-induced tardive dyskinesia

    Intervention Review

    The Cochrane Library

    Adib Essali, Hany Deirawan, Karla Soares-Weiser and Clive E Adams

    Published Online : 9 NOV 2011, DOI: 10.1002/14651858.CD000206.pub3

  14. 2nd World Parkinson Congress Abstracts

    Movement Disorders

    Volume 25, Issue S3, 15 September 2010, Pages: S569–S717,

    Version of Record online : 9 SEP 2010, DOI: 10.1002/mds.23386

    Corrected by:

    Erratum: Erratum

    Vol. 25, Issue 15, 2694, Version of Record online: 10 NOV 2010

  15. Neural mechanisms underlying peak-dose dyskinesia induced by levodopa and apomorphine are distinct: Evidence from the effects of the alpha2 adrenoceptor antagonist idazoxan

    Movement Disorders

    Volume 16, Issue 4, July 2001, Pages: 642–650, Susan H. Fox, Brian Henry, Micheal P. Hill, David Peggs, Alan R. Crossman and Jonathan M. Brotchie

    Version of Record online : 16 JUL 2001, DOI: 10.1002/mds.1148

  16. You have free access to this content
    Pyridoxal 5 phosphate for neuroleptic-induced tardive dyskinesia

    Intervention Review

    The Cochrane Library

    Adegoke Oloruntoba Adelufosi, Olukayode Abayomi and Tunde Massey-Ferguson Ojo

    Published Online : 13 APR 2015, DOI: 10.1002/14651858.CD010501.pub2

  17. Levodopa-induced dyskinesias

    Movement Disorders

    Volume 22, Issue 10, 30 July 2007, Pages: 1379–1389, Giovanni Fabbrini, Jonathan M. Brotchie, Francisco Grandas, Masahiro Nomoto and Christopher G. Goetz

    Version of Record online : 11 APR 2007, DOI: 10.1002/mds.21475

  18. Therapies for dopaminergic-induced dyskinesias in parkinson disease

    Annals of Neurology

    Volume 69, Issue 6, June 2011, Pages: 919–927, Mildred D. Gottwald and Michael J. Aminoff

    Version of Record online : 16 JUN 2011, DOI: 10.1002/ana.22423

  19. Benzodiazepines for neuroleptic-induced tardive dyskinesia

    Intervention Review

    The Cochrane Library

    Paranthaman Sethupathi Bhoopathi and Karla Soares-Weiser

    Published Online : 19 JUL 2006, DOI: 10.1002/14651858.CD000205.pub2

  20. Treatment of levodopa-induced motor complications

    Movement Disorders

    Volume 23, Issue S3, 2008, Pages: S599–S612, Fabrizio Stocchi, Michele Tagliati and C. Warren Olanow

    Version of Record online : 9 SEP 2008, DOI: 10.1002/mds.22052